Pages that link to "Q50571194"
Jump to navigation
Jump to search
The following pages link to The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers (Q50571194):
Displaying 28 items.
- HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer (Q33613602) (← links)
- BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy (Q34491903) (← links)
- Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer (Q34825969) (← links)
- Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy (Q35149589) (← links)
- Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer (Q35190290) (← links)
- Mutant p53 protein expression and antioxidant status deficiency in breast cancer (Q35729171) (← links)
- Expression of WTH3 in breast cancer tissue and the effects on the biological behavior of breast cancer cells (Q35803468) (← links)
- Calpain system protein expression in basal-like and triple-negative invasive breast cancer (Q36182357) (← links)
- Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells. (Q36546592) (← links)
- Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women (Q36830014) (← links)
- Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature. (Q36959186) (← links)
- Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer (Q37085951) (← links)
- Immunophenotypic and genomic characterization of papillary carcinomas of the breast (Q37130628) (← links)
- Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection (Q37155717) (← links)
- MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability (Q37686014) (← links)
- Translating p53 into the clinic. (Q37803120) (← links)
- Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts. (Q38937671) (← links)
- Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach (Q39672356) (← links)
- SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. (Q39677335) (← links)
- Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival (Q41903427) (← links)
- Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients (Q42517538) (← links)
- Subcellular localization of Mdm2 expression and prognosis of breast cancer. (Q45996309) (← links)
- High nuclear MSK1 is associated with longer survival in breast cancer patients (Q48256291) (← links)
- The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2. (Q49511046) (← links)
- [Histological grading of breast cancer]. (Q53075565) (← links)
- Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands (Q89441848) (← links)
- Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4 (Q90229840) (← links)
- Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges (Q98771287) (← links)